- Management of fibromyalgia
Coverage of drugs is first determined by the member’s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.
AND
Drug | Dosing Regimen | Dose Limit/ Maximum Dose |
---|---|---|
duloxetine (CymbaltaR) | Fibromyalgia: | 60 mg/day |
LyricaR* (pregabalin)**
| Fibromyalgia: | 450 mg/day |
Drug | Dosing Regimen | Authorization Limit |
---|---|---|
Savella | The recommended dose of Savella is 100 mg/day (50 mg PO BID). Dosing should be titrated to 100 mg/day over a 1-week period: Day 1: 12.5 mg once PO Days 2-3: 25 mg/day (12.5 mg PO BID) Days 4-7: 50 mg/day (25 mg PO BID) After Day 7: 100 mg/day (50 mg PO BID) May be increased to 200 mg/day (100 mg PO BID) based on individual response. Doses above 200 mg/day have not been studied. For patients with severe renal impairment (indicated by an estimated creatinine clearance of 5-29mL/min), the maintenance dose should be reduced by 50% to 50 mg/day (25 mg PO BID). Savella is not recommended for patients with end-stage renal disease. | Length of benefit |
Tablets: 12.5 mg, 25 mg, 50 mg, 100 mg